Skip to main content

Marta Rebull Santamaria

Institutions of which they are part

Research technician
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Marta Rebull Santamaria

Institutions of which they are part

Research technician
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Estudio preclínico de la combinación de terapias anti-HER2 e inhibidores de PARP en el cáncer de endometrio HER2 positivo con Deficiencia de Recombinación Homóloga (HRD).

IP: Valeria Tubita
Collaborators: Francesc Xavier Serra Marin, Eva Colas Ortega, Antonio Gil Moreno, Marta Rebull Santamaria, Lourdes Elena Salazar Huayna
Funding agency: Asociación Española Contra el Cáncer
Funding: 8539.84
Reference: SNRGS259715TUBI
Duration: 01/12/2025 - 30/11/2027

Búsqueda de firmas proteómicas y dianas terapéuticas en el cáncer de ovario seroso de alto grado avanzado resistente a platino

IP: Antonio Gil Moreno
Collaborators: Vicente Bebia Conesa, Francesc Xavier Serra Marin, Marta Rebull Santamaria, Martina Angeles Fite, Melissa Bradbury Lobato, Lourdes Elena Salazar Huayna, Búsqueda de firmas proteómicas y dianas terapéuticas en el cáncer de ovario seroso de alto grado avanzado resistente a platino, Melek Denizli , Valeria Tubita
Funding agency: Instituto de Salud Carlos III
Funding: 196250
Reference: PI24/01509
Duration: 01/01/2025 - 31/12/2027

ScreenEC, validació d'una eina de triatge no invasiu en càncer d'endometri

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Francesc Xavier Serra Marin, Josep Castellví Vives, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Lourdes Elena Salazar Huayna
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 99946
Reference: SLT036/24/000059
Duration: 21/12/2024 - 31/12/2026

Desarrollo de CEMARK-Px, un método in vitro para el diagnóstico objetivo y preciso del tipo y grado histológico del cáncer de endometrio en fluido uterino

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Lourdes Elena Salazar Huayna, Melek Denizli
Funding agency: Instituto de Salud Carlos III
Funding: 278300
Reference: DTS23/00091
Duration: 01/01/2024 - 31/12/2026

Related news

The Biomedical Research in Gynaecology group at VHIR has contributed to this international resource with endometrial cancer organoid models.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study evaluated the results of combining SYD985, a HER2 antibody conjugated to a potent cytotoxic drug, and niraparib, an inhibitor of DNA damage repair.

Related professionals

Júlia Cera Puig

Júlia Cera Puig

Research technician
Clinical Pharmacology
Read more
Israel Gutierrez Plaza

Israel Gutierrez Plaza

Research technician
Gene and Cell Therapy
Read more
Carles Zafon Llopis

Carles Zafon Llopis

Main researcher
Diabetes and Metabolism
Read more
Yolanda Domingo Gásquez

Yolanda Domingo Gásquez

Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.